Market News AIOpen the app

BFRI stock news · Biofrontera

Stories about Biofrontera (BFRI) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for BFRI

Follow Biofrontera (BFRI) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for BFRI
Free on the App Store and Google Play, or on the web.
  1. Oct 5, 2026, 5:16 PM ET · Market

    Here are 12 health care stocks that changed in value after the market closed on Monday.

    Neutral

    Biofrontera shares rose in after-hours trading. The report gives no business reason for the move, so it does not change the company's outlook.

  2. Sep 14, 2026, 9:47 AM ET · Trial

    Biofrontera Inc. says it got FDA approval for its Ameluz gel to treat skin cancer.

    Good for BFRI

    Biofrontera reported FDA approval of Ameluz plus BF-RhodoLED for superficial basal cell carcinoma. I read this as a favorable development for the company's commercial prospects.